COLLIS STEVEN H 4

What Happened

• Steven H. Collis, a director of Elevance Health, received an award of 563 deferred stock units on May 13, 2026. The units were granted at $0.00 per share (no cash exchanged) and reported on a Form 4 filed May 15, 2026. The reported transaction code is "A" (award/grant).

Key Details

• Transaction date: 2026-05-13; Filing date: 2026-05-15 (Form 4 accession 0001191508-26-000004).
• Amount: 563 deferred stock units; Reported price: $0.00; Reported value: $0.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: F1 — Units are deferred stock units under the Company's Board of Directors Compensation Program. F2 — Units will be payable in common stock upon the earlier of (a) five years from grant or (b) the date the director ceases board service, unless a later payout date was elected under the Deferred Compensation Plan.
• Timeliness: Filing appears timely (filed within the standard Form 4 reporting window); no late filing flag noted.

Context

• This was an award of deferred stock units (a form of director compensation), not an open-market purchase or sale. Deferred units convert to common stock under the terms described above, so the grant does not represent an immediate cash transaction or market sale. Such grants are routine for board compensation and don't, by themselves, indicate a buy/sell signal.